The need for new test verification and regulatory support for innovative diagnostics

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2021-09, Vol.39 (9), p.1060-1062
Hauptverfasser:	Roback, John D., Tyburski, Erika A., Alter, David, Asakrah, Saja, Chahroudi, Ann, Esper, Annette, Farmer, Sarah, Figueroa, Janet, K. Frediani, Jennifer, D. Gonzalez, Mark, S. Gottfried, David, Guarner, Jeannette, A. Gupta, Nitika, S. Heilman, Stacy, E. Hill, Charles, Jerris, Robert, R. Kempker, Russell, Ingersoll, Jessica, Levy, Joshua M., Mavigner, Maud, S. Moreno, Carlos, R. Morris, Claudia, J. Nehl, Eric, S. Neish, Andrew, Peker, Deniz, Saakadze, Natia, Rebolledo, Paulina A., A. Rostad, Christina, Schoof, Nils, Suessmith, Allie, Sullivan, Julie, Wang, Yun F. (Wayne), Wood, Anna, Vos, Miriam B., Brand, Oliver, Martin, Greg S., Lam, Wilbur A.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/575 706/648/1496 706/703/559 Agriculture Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Control Correspondence COVID-19 - diagnosis COVID-19 - virology COVID-19 Testing - standards Epidemics Forecasts and trends Humans Laws, regulations and rules Life Sciences Medical tests Methods National Institutes of Health (U.S.) - legislation & jurisprudence SARS-CoV-2 - isolation & purification United States United States Food and Drug Administration - legislation & jurisprudence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!